DRAINHUNT
DEAD

Serial Number

79205165

Owner

Immungenetics AG

Filing Date

Sep 30, 2016

Add to watchlist:

No watchlists yet
View on USPTO

DRAINHUNT Trademark

Serial Number: 79205165 • Registration: 5388879

DRAINHUNT is a trademark filed by Immungenetics AG on September 30, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Immungenetics AG (3 trademarks)

Eifflerstr. 43

Entity Type: 25

Trademark Details

Filing Date

September 30, 2016

Registration Date

January 30, 2018

Published for Opposition

November 14, 2017

Cancellation Date

August 16, 2024

Goods & Services

Biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for use in neurodegenerative diseases; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for use in trinucleotide repeat disorders, in particular for use in Huntington's Chorea; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for preventing neurodegenerative diseases; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for preventing trinucleotide repeat disorders, in particular for preventing Huntington's Chorea; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for the treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for the treatment of trinucleotide repeat disorders, in particular for the treatment of Huntington'a chorea; biochemical and chemical preparations for medical purposes in oral administration forms, namely, pills, tablets, dragées, capsules, liquids, drops, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in oral administration forms, namely, pills, tablets, dragées, capsules, liquids, drops, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of trinucleotide repeat disorders; biochemical and chemical preparations for medical purposes in oral administration forms, namely, pills, tablets, dragées, capsules, liquids, drops, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of Huntington's Chorea; biochemical and chemical preparations for medical purposes in parenteral administration forms, namely, injection solutions and infusion solutions, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in parenteral administration forms, namely, injection solutions and infusion solutions, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of trinucleotide repeat disorders; biochemical and chemical preparations for medical purposes in parenteral administration forms, namely, injection solutions and infusion solutions, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of Huntington's chorea

Chemical products for the production of viral, retroviral and non-viral vectors

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Aug 8, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jul 17, 2025 INTS
INVALIDATION PROCESSED
Jul 17, 2025 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 16, 2025 INTR
CANCELLED SECTION 71
Aug 16, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 30, 2023 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 11, 2022 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Mar 11, 2022 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 12, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 8, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 2, 2018 FICS
FINAL DISPOSITION PROCESSED
May 2, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 30, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 30, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 14, 2017 NPUB
PUBLISHED FOR OPPOSITION
Nov 14, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 25, 2017 NONP
ASSIGNED TO LIE
Oct 9, 2017 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 23, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 20, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 19, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 19, 2017 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 19, 2017 TCCA
REFUSAL PROCESSED BY IB
May 5, 2017 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 19, 2017 RFCS
REFUSAL PROCESSED BY MPU
Apr 19, 2017 RFRR
APPLICATION FILING RECEIPT MAILED
Apr 19, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 16, 2017 RFCR
NON-FINAL ACTION WRITTEN
Apr 15, 2017 CNRT
ASSIGNED TO EXAMINER
Apr 15, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 15, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 13, 2017 REPR